Unlabelled: Pedometers could provide great insights into walking habits if they are found to be accurate for people of all weight categories.
Purpose: the purposes of this study were to determine whether the New Lifestyles NL-2000 (NL) and the Digi-Walker SW-200 (DW) yield similar daily step counts as compared with the StepWatch 3 (SW) in a free-living environment and to determine whether pedometer error is influenced by body mass index (BMI) and speed of walking. The SW served as the criterion because of its accuracy across a range of speeds and BMI categories. Slow walking was defined as ≤80 steps per minute.
Methods: fifty-six adults (mean ± SD: age = 32.7 ± 14.5 yr) wore the devices for 7 d. There were 20 normal weight, 18 overweight, and 18 obese participants. A two-way repeated-measures ANOVA was performed to determine whether BMI and device were related to number of steps counted per day. Stepwise linear regressions were performed to determine what variables contributed to NL and DW error.
Results: both the NL and the DW recorded fewer steps than the SW (P < 0.001). In the normal weight and overweight groups, error was similar for the DW and NL. In the obese group, the DW underestimated steps more than the NL (P < 0.01). DW error was positively related to BMI and percentage of slow steps, whereas NL error was linearly related to percentage of slow steps. A surprising finding was that many healthy, community-dwelling adults accumulated a large percentage of steps through slow walking.
Conclusions: the NL is more accurate than the DW for obese individuals, and neither pedometer is accurate for people who walk slowly. Researchers and practitioners must weigh the strengths and limitations of step counters before making an informed decision about which device to use.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1249/MSS.0b013e3181e9b133 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
External Validation of a 5-Factor Risk Model for Breast Cancer-Related Lymphedema.
JAMA Netw Open
January 2025
Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Importance: Secondary lymphedema is a common, harmful side effect of breast cancer treatment. Robust risk models that are externally validated are needed to facilitate clinical translation. A published risk model used 5 accessible clinical factors to predict the development of breast cancer-related lymphedema; this model included a patient's mammographic breast density as a novel predictive factor.
View Article and Find Full Text PDFAge at Menopause and Development of Type 2 Diabetes in Korea.
JAMA Netw Open
January 2025
Department of Family Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Importance: There is limited evidence regarding the association between age at menopause and incident type 2 diabetes (T2D).
Objective: To investigate whether age at menopause and premature menopause are associated with T2D incidence in postmenopausal Korean women.
Design, Setting, And Participants: This population-based cohort study was conducted among a nationally representative sample from the Korean National Health Insurance Service database of 1 125 378 postmenopausal women without T2D who enrolled in 2009.
Effect of Pediatric Obesity Treatment on Long-Term Health.
JAMA Pediatr
January 2025
Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Importance: Data regarding the long-term impact of treating childhood obesity on the risk of obesity-related events, including premature mortality, are limited.
Objective: To evaluate the long-term effect of different responses to pediatric obesity treatment on critical health outcomes in young adulthood.
Design, Setting, And Participants: The study included a dynamic prospective cohort of children and adolescents with obesity within The Swedish Childhood Obesity Treatment Register (BORIS) and general population comparators, linked with national registers.
CaMKIIγ advances chronic intermittent hypoxia-induced cardiomyocyte apoptosis via HIF-1 signaling pathway.
Sleep Breath
January 2025
Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, and Research Institution of Translational Medicine in Cardiothoracic Diseases, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China.
Background: Our previous study have demonstrated chronic intermittent hypoxia (CIH) induced cardiomyocyte apoptosis and cardiac dysfunction. However, the molecular mechanisms are complicated and varied. In this study, we first investigated the CaMKIIγ expression and signaling pathway in the pathogenesis of cardiomyocyte apoptosis after CIH.
View Article and Find Full Text PDFOnabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial.
Int Urogynecol J
January 2025
Department of Urogynecology and Reconstructive Pelvic Surgery, Atlantic Health System, 435 South Street, Suite 370, Morristown, NJ, 07960, USA.
Introduction And Hypothesis: The objective of our study was to evaluate the need for antibiotic prophylaxis for urinary tract infection (UTI) prevention before Onabotulinum toxin A injection for overactive bladder (OAB). We hypothesize that the lack of antibiotic prophylaxis might not be inferior to administering prophylaxis.
Methods: This was a multi-centered, nonblinded, randomized controlled trial conducted between August 2022 and September 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!